Joshua Weisbrod, a partner in Bain & Company's global Healthcare and Private Equity practices, discusses how private equity investors can get comfortable with healthcare-heavy businesses and the risk inherently attached to them. "Healthcare-heavy investing is not playing the lottery and hoping your number doesn’t come up," says Weisbrod. "Investors who are successful in healthcare-heavy deals can bound the risk appropriately."